
A newsletter about multiple myeloma for patients, caregivers, and advocates.
| Platform | Pricing | Only free issues | Publishes | Infrequently | |
|---|---|---|---|---|---|
| Issues | 7 | Subscribers | Read | myelomafighters.substack.com |
Curious about how many subscribers Multiple Myeloma Fighters has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Recent posts by this newsletter. Browse the email archive.
My biggest fear about LLMs and AI in medicine and oncology is that instead of allowing physicians to determine how to use LLMs best, we will be tasked with overseeing the LLMs “helping” us do our work.
Infection is a leading cause of death in the complex treatment landscape of myeloma, making broad-spectrum antibiotics critical in combating severe infections. However, these powerful medications carry significant risks, including the poten...
As a myeloma specialist, typically, two kinds of patients come to me for a second opinions or consultations about their disease. Newly diagnosed patients want an opinion about having an autologous stem cell transplant. Patients who have rel...
The scourge of many Multiple Myeloma patients is peripheral neuropathy – a condition which causes weakness, numbness, and pain, typically in the hands and feet, but it can also affect other areas of the body. . Neuropathy is often caused b...
Other publications recommended by the authors of this newsletter.
The writers behind this newsletter.
I am a medical oncologist at BC Cancer Agency who focuses on treatment and research in multiple myeloma. My research interests include clinical trials, AI in medicine, novel biomarkers, and immunotherapy.
Dr. Fonseca is the Getz Family Professor of Cancer, Chief Innovation Officer at the Mayo Clinic in Arizona. Dr Fonseca focuses on the research, diagnosis and treatment of myeloma and related plasma cell disorders.
Tech marketing writer turned memoirist; currently working on a book about the relationships between early life trauma and treatment for late life critical illness.
Myeloma Patient since 2015, facilitator of the Northwest Multiple Myeloma Fighters support group
You can find recent issues that have been published by Multiple Myeloma Fighters on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Multiple Myeloma Fighters, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Multiple Myeloma Fighters as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Multiple Myeloma Fighters using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like Multiple Myeloma Fighters. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.